These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1392676)

  • 1. Oral anticoagulation therapy: indications, contraindications, and complications.
    Donhou GE
    Nurse Pract Forum; 1992 Jun; 3(2):86-94. PubMed ID: 1392676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the implications of oral anticoagulation therapy.
    Gallagher D; Rix E
    Nurs Times; 2006 Jun 20-26; 102(25):30-2. PubMed ID: 16826947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral anticoagulant therapy: practical considerations.
    Ansell JE; Holden A; Nozzolillo E
    Nurse Pract Forum; 1992 Jun; 3(2):105-13. PubMed ID: 1392666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing oral anticoagulation therapy: improving clinical outcomes. A review.
    Ryan F; Byrne S; O'Shea S
    J Clin Pharm Ther; 2008 Dec; 33(6):581-90. PubMed ID: 19138235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Self testing and self management of oral anticoagulants with warfarin].
    Nadav L; Schwartz J
    Harefuah; 2003 Sep; 142(8-9):621-3, 645, 644. PubMed ID: 14518167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current recommendations for prevention of thromboembolism in patients with heart valve prostheses].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 6():112-7. PubMed ID: 11826813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term anticoagulation. Indications and management.
    Stults BM; Dere WH; Caine TH
    West J Med; 1989 Oct; 151(4):414-29. PubMed ID: 2686173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral anticoagulation therapy in the primary care setting].
    Vinker S; Nakar S; Finkel S; Nir E; Hyam E
    Harefuah; 1997 Jun; 132(11):753-6, 824, 823. PubMed ID: 9223814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.
    Phillips KW; Ansell J
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):57-70. PubMed ID: 18095907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy.
    Varkarakis IM; Rais-Bahrami S; Allaf ME; Lima GC; Permpongkosol S; Rao P; Jarrett TW; Kavoussi LR
    J Urol; 2005 Sep; 174(3):1020-3; discussion 1023. PubMed ID: 16094036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.
    Watzke HH; Forberg E; Svolba G; Jimenez-Boj E; Krinninger B
    Thromb Haemost; 2000 May; 83(5):661-5. PubMed ID: 10823258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticoagulation in pregnancy and post partum in heat valve diseases, thrombosis or atrial fibrillation: fetal risk versus maternal thromboembolism].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 4():49-56. PubMed ID: 11373944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral anticoagulant treatment].
    Melis Tormos E
    Rev Enferm; 2009 May; 32(5):48-54. PubMed ID: 19552155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of oral anticoagulation therapy by INR self-management.
    Horstkotte D; Piper C
    J Heart Valve Dis; 2004 May; 13(3):335-8. PubMed ID: 15222277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Present and future of oral anticoagulants].
    Meschengieser SS; Casais P; Sánchez Luceros A; Lazzari MA
    Medicina (B Aires); 2000; 60(1):139-42. PubMed ID: 10835711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.